Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 July 2019 | Story Zamuxolo Feni | Photo Johan Roux
Photo-MedicalStudents
Head of the University of the Free State School of Clinical Medicine Prof Nathaniel Mofolo (left) standing with the medical students who were about to board one of the newly-introduced vehicles that will ferry students to and from their work stations for their practical training.

In an effort to ensure the safety and convenience of undergraduate students doing their practical training at clinical platforms in Bloemfontein, the University of the Free State (UFS) – in collaboration with the Free State Department of Health (DoH) – has initiated a programme to transport undergraduate students to and from the respective clinical platforms.

UFS and Free State Department of Health joining forces for student safety

The Department of Health is providing a fleet of six minibuses and Kombis, as well as drivers for the vehicles. The transport is available to the students at no cost, from 06:00 to 23:00 every day as well as on weekends and public holidays.

Prof Nathaniel Mofolo, Head of the School of Clinical Medicine at the UFS, said, “This is the first initiative of its kind that the university has had with the provincial Department of Health. We are thankful for this initiative, as it will greatly assist in securing the safety of our students.”

More students from Health Sciences set to benefit

The initiative started on the morning of 8 July 2019, when groups of medical students boarded mini-buses and Kombis to the Pelonomi Hospital, National Hospital, Free State Psychiatric Complex, and the Mangaung University Community Partnership Programme (MUCPP).

Prof Mofolo said there was a firm intention from both parties to extend the programme to undergraduate students in the School of Nursing, as well as to students in the School of Allied Health Professions during August 2019.

According to Prof Mofolo, the decision to implement the transport programme was taken after student safety and wellness concerns were taken into consideration. “Although students can make use of the service on a voluntary basis, we have already received feedback that the service is being put to good use,” said Prof Mofolo.

The safety of undergraduate students doing their practical training at Pelonomi Hospital has been in the spotlight last month after the attempted rape of a medical intern, as well as the robbery of a medical officer in the parking area of the hospital. “We are hopeful that the transport programme will prevent the occurrence of similar incidents,” said Prof Mofolo.

Over the past month, the UFS, the DoH, and the executive management of Pelonomi Hospital have been working tirelessly to ensure the implementation of an agreed Safety and Security Plan, hence placing the safety of students, staff, and patients first.

 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept